Laurence Bernstein

Quest Diagnostics (United States)

Papers

1

Total Citations

26

H-Index

1

About

Laurence Bernstein is a clinical molecular biologist whose work sits at the critical intersection of viral genomics and public health preparedness. His primary research focus is the development and validation of high-throughput sequencing workflows for emerging pathogens, most notably demonstrated during the COVID-19 pandemic. Bernstein’s landmark study, “Development and validation of a high throughput SARS-CoV-2 whole genome sequencing workflow in a clinical laboratory,” has garnered 26 citations and established a reproducible, clinically actionable framework for monitoring viral mutations in real time. This work directly enabled the identification of new diagnostic and therapeutic targets, providing essential insights for more effective outbreak control strategies. By translating complex next-generation sequencing (NGS) technologies into practical clinical laboratory protocols, Bernstein has helped bridge the gap between cutting-edge genomics and frontline pandemic response. His contributions are particularly valuable for students and researchers interested in clinical virology, genomic epidemiology, and the operational challenges of deploying advanced molecular tools under public health urgency.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Development and validation of a high throughput SARS-CoV-2 whole genome sequencing workflow in a clinical laboratory
26 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Quest Diagnostics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago